Press release
Lupus Nephritis - Pipeline Assessment, 2023 Updates | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | Equillium Bio, Hoffmann-La Roche Ltd, Genentech Inc, Genovax S.r.l.
Lupus Nephritis
Download PDF Sample Pages to Get an in-depth Assessment of the Emerging Therapies and Key Companies : https://www.globalinsightservices.com/request-sample/GIS31229
Lupus Nephritis is an autoimmune kidney disease caused by systemic lupus erythematosus (SLE). It is a type of glomerulonephritis where autoantibodies affect the structures of glomeruli which results in inflammation and decreased kidney output.
Lupus Nephritis is mainly of 6 types, following minimal mesangial glomerulonephritis, mesangial proliferative glomerulonephritis, focal glomerulonephritis, diffuse proliferative nephritis, membranous glomerulonephritis and advanced sclerosing lupus nephritis.
Report Highlights
Global Insight Service's, Lupus Nephritis - Drug Pipeline Landscape, 2023 report provides an overview of the Lupus nephritis pipeline drugs. This report covers detailed insights on Lupus Nephritis drugs under development, assessment by target, mechanism of action, route of administration and molecule type. Product pipeline by companies, stage of development and key regulatory designations, deals and milestones have been presented to provide insights and thus help industry participants in their decision making. Lupus Nephritis pipeline report helps gain insights on drugs which are under development stage of drug development process across globally.
Methodology
The research process includes extensive secondary research on public domain and other authentic sources to add or update the pipeline products information. The secondary research sources include, but are not limited to company websites, annual reports, financial reports, company pipeline chart, investor presentations and SEC filings, journals and conferences, and clinical trials registries.
Scope
The pipeline landscape report provides analysis of pipeline products based on several stages of development ranging from Discovery to Pre-Registration. The report provides a review of pipeline therapeutics by companies based on information derived from company and industry-specific sources. The pipeline report covers assessment of therapeutics by mechanism of action (MoA), drug target, route of administration (RoA) and molecule type. Comprehensive profiles of the pipeline products with details such as company overview, development stage; molecule type, target, mechanism of action, route of administration, dosage form, regulatory designations, key deals, clinical trials, and key upcoming milestones are included.
Key Players
• Alexion Pharmaceuticals
• Ampio Pharmaceuticals Inc
• Asahi Kasei Pharma Corporation
• AstraZeneca
• BeiGene Inc
• BioAegis Therapeutics Inc
• Boehringer Ingelheim
• Cellenkos Inc
• ChemoCentryx Inc
• Corestem Inc
• Eledon Pharmaceuticals Inc
• Equillium Bio
• Hoffmann-La Roche Ltd
• Genentech Inc
• Genovax S.r.l.
• Horizon Therapeutics plc
Buy Now : https://www.globalinsightservices.com/checkout/single_user/GIS31229
Report Covers the Emerging Pipeline Products Under Different Phases of Clinical Development Like -
- Late-stage products (Phase III)
- Mid-stage products (Phase II)
- Early-stage product (Phase I)
- Pre-clinical and Discovery stage candidates
- Discontinued & Inactive candidates
Contact Us:
Global Insight Services LLC
16192, Coastal Highway, Lewes DE 19958
E-mail: info@globalinsightservices.com
Phone: +1-833-761-1700
Website: https://www.globalinsightservices.com/
About Global Insight Services:
Global Insight Services (GIS) is a leading multi-industry market research firm headquartered in Delaware, US. We are committed to providing our clients with highest quality data, analysis, and tools to meet all their market research needs. With GIS, you can be assured of the quality of the deliverables, robust & transparent research methodology, and superior service.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Lupus Nephritis - Pipeline Assessment, 2023 Updates | In-depth Insights into the Clinical Trials, Emerging Drugs, Latest FDA, EMA, and PMDA Approvals, and Treatment Outlook | Equillium Bio, Hoffmann-La Roche Ltd, Genentech Inc, Genovax S.r.l. here
News-ID: 2951440 • Views: …
More Releases from Global Insight Services
Hydrogen Generation Market Poised to Grow from $155.5 Billion in 2024 to $410.6 …
The Hydrogen Generation Market is set to experience remarkable growth, expanding from $155.5 billion in 2024 to an estimated $410.6 billion by 2034, registering a robust CAGR of approximately 10.2%. Hydrogen generation involves producing and supplying hydrogen through various techniques, including steam methane reforming, electrolysis, and coal gasification. This market plays a pivotal role in supporting industries seeking cleaner energy solutions, spanning transportation, power generation, and industrial processes. As the…
Identity and Access Management Market Poised to Grow from $15.9 Billion in 2024 …
The Identity & Access Management (IAM) market is poised for substantial growth, expanding from an estimated $15.9 billion in 2024 to $38.2 billion by 2034 at a robust CAGR of approximately 9.2%. IAM encompasses systems, tools, and policies that manage digital identities and regulate user access within organizations. This includes solutions such as authentication, single sign-on, identity governance, and privileged access management. These technologies are essential for ensuring security, compliance,…
Endoscopy Devices Market Is Anticipated To Expand From $14.5 Billion In 2024 To …
Market Overview
The Endoscopy Devices Market is playing an increasingly important role in modern healthcare by supporting minimally invasive diagnostic and surgical procedures. These devices, which include endoscopes, visualization systems, and complementary instruments, allow physicians to examine internal organs with precision, leading to faster diagnoses, less trauma for patients, and improved recovery times. As the global burden of chronic diseases rises, the demand for such technologies continues to expand. Additionally, advancements…
Sustainable Fashion Market Is Anticipated To Expand From $13.8 Billion In 2024 T …
Market Overview
The Sustainable Fashion Market has gained remarkable momentum in recent years as consumers, brands, and policymakers increasingly recognize the need for eco-friendly and socially responsible alternatives in the fashion industry. Unlike conventional fashion, which is often criticized for its high carbon footprint and exploitative labor practices, sustainable fashion emphasizes the use of organic, recycled, and biodegradable materials, along with ethical supply chains and fair trade principles. This shift represents…
More Releases for Lupus
Cutaneous Lupus Erythematosus (CLE) Market
Introduction
Cutaneous Lupus Erythematosus (CLE) is a chronic autoimmune skin disorder, often associated with systemic lupus erythematosus (SLE), that presents as inflammation, rashes, and photosensitivity. While CLE is rarely fatal, it significantly affects patients' physical and emotional well-being, often leading to scarring, disfigurement, and social stigma.
Over the past decade, the market for CLE therapies has gained global importance as research into autoimmunity has accelerated and biologic therapies have transformed dermatology. Rising…
Prominent Cutaneous Lupus Erythematosus Market Trend for 2025: Advancements In C …
What combination of drivers is leading to accelerated growth in the cutaneous lupus erythematosus market?
The rising prevalence of skin infections is expected to drive the growth of the cutaneous lupus erythematosus (CLE) market. Skin infections are caused by microorganisms that invade the skin, triggering immune responses that can worsen symptoms in individuals with CLE. For example, the UK saw a 33.7% increase in MRSA cases caused by skin and soft…
Cutaneous Lupus Erythematosus (CLE) Market
Market Overview:
The Global Cutaneous Lupus Erythematosus (CLE) Market is forecasted to achieve a High CAGR during the period 2023-2030. CLE encompasses a spectrum of dermatological symptoms that may precede or accompany systemic lupus erythematosus (SLE), an autoimmune condition impacting multiple organs. Timely diagnosis and treatment of CLE can prevent the onset of severe systemic symptoms.
Market Dynamics:
Drivers:
Rise in Clinical Studies: Technological advancements leading to faster and accurate diagnosis have spurred additional…
Lupus Nephritis Treatment Market 2030
Global Lupus Nephritis Treatment market is expected to be worth roughly USD 8,048 million by 2030, growing at a CAGR of 7.3% during the forthcoming period of 2022-2030, according to Ameco Research
Lupus nephritis is one of the most rapidly spreading diseases over the globe. The increasing frequency of lupus nephritis and consumer awareness has fuelled the worldwide lupus nephritis treatment market. Another crucial factor driving the pace of growth of…
Lupus Erythematosus Market -API Insights, 2017
Summary
Orbis Research Present “Lupus Erythematosus-API Insights, 2017”
Description
The active pharmaceutical ingredients worldwide market is in continuous development from the recent years. There is expected to be a major impact on the global API industry, with the large number of blockbuster drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market.
India and China produce a large percentage…
Global Systemic Lupus Erythematosus and Lupus Nephritis Market to Display 10.6% …
"The Report PharmaPoint: Systemic Lupus Erythematosus and Lupus Nephritis - Global Drug Forecast and Market Analysis to 2025 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. - MarketResearchReports.biz"
MarketResearchReports.biz has announced the addition of a new report, titled “PharmaPoint: Systemic Lupus Erythematosus And Lupus Nephritis - Global Drug Forecast And Market Analysis To 2025,” to its expanding repository of research reports. The market…
